Abstinence versus agonist maintenance treatment: an outdated debate?
نویسنده
چکیده
ate brief wellbeing measures could facilitate discussions about broader life needs to be addressed. Further, insights from the literature on subjective wellbeing may inform services and interventions to help people establish happier, more meaningful lives within which addiction holds less attraction.’ The increasing acceptance and availability of agonist maintenance treatment is well documented: in Europe, the number of countries providing methadone maintenance increased from 7 in 1980 to 28 by 2005, and the number of countries providing buprenorphine maintenance rose within a few years to 21 [2] . Globally, opioid maintenance treatment was available in 70 countries by 2009 [3] . Even an increasing number of prison systems are offering methadone maintenance treatment to prisoners [4] . Driving forces were the HIV/AIDS epidemic among drug injectors with increasing risks for the general population, and the ensuing need to bring as many injectors as possible into treatment arrangements. Have the expectations been met? The research evidence is quite clear and has been well documented and reviewed. The World Health Organisation has included methadone and buprenorphine, the two mainly used agonists in maintenance treatment, into the lists of essential medicines and summarized the state of research results After two decades of increasing acceptance and availability of agonist maintenance therapies, we hear more about limitations of this approach and about a new quest for abstinence-oriented recovery. What is the state of these trends, and what are the facts and arguments? Part of this development is already visible from the differential terminology in use: abstinence is perceived as instrumental for health and social improvements (‘abstinence-based therapy’) or else as the final objective (‘abstinence-oriented therapy’). Recovery is used to describe a rehabilitation process in various shades (‘back to normal’), but also to describe a socialization process to model citizenship (‘better than well’). Maintenance therapy goes as a temporary approach to engage those in treatment who otherwise cannot be reached (‘maintenance to abstinence’) or else as the treatment of a chronic condition (‘unlimited maintenance’). The diverse terms mirror dissatisfaction with the crude opposition abstinence versus maintenance, but in fact they present a new version of the old controversy: what are the goals of addiction treatment? Is the ultimate goal abstinence, or is it well-being with or without abstinence? In other words [1] : ‘To what extent is your program making peoples’ lives better, rather than simply suppressing alcohol/drug use? Structured assessment using appropriPublished online: May 7, 2013 European Addiction c Re e s ar h
منابع مشابه
From opioid maintenance to abstinence: a literature review.
It appears that the literature on agonist maintenance therapies for opioid dependence pays more attention to outcomes during, rather than after, treatment. This review aims to (a) estimate to what extent opioid abstinence can be expected from former maintenance patients, (b) examine possible relationships between patient and treatment characteristics and abstinence rates and (c) assess the need...
متن کاملTreating Opioid Dependence With Injectable Extended-Release Naltrexone (XR-NTX)
OBJECTIVES Once-monthly intramuscular extended-release naltrexone (XR-NTX) has demonstrated efficacy for the prevention of relapse in opioid dependence, providing an alternative to agonist or partial agonist maintenance (ie, methadone and buprenorphine). The question remains, for whom is this unique treatment most efficacious and can patient-treatment matching factors be identified? METHODS A...
متن کاملIn Review Evidence-Based Treatment of Opioid-Dependent Patients
Results: Both clinical experience and neurobiological evidence indicate that opioid dependence is a chronic relapsing disorder. Treatment objectives depend on the pursued goals: crisis intervention, abstinence-oriented treatment (detoxification and relapse prevention), or agonist maintenance treatment. The high quality of solid evidence in the literature demonstrates that there are numerous eff...
متن کاملEffect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial.
CONTEXT The majority of cigarette smokers who achieve abstinence relapse within the first year and require many attempts before achieving permanent abstinence. Evidence to support pharmacological treatment for relapse prevention is insufficient. OBJECTIVE To determine whether smokers who quit after 12 weeks of treatment with varenicline, a selective alpha4beta2 nicotinic acetylcholine recepto...
متن کاملComparative effectiveness of intervention components for producing long-term abstinence from smoking: a factorial screening experiment.
AIMS To identify promising intervention components that help smokers attain and maintain abstinence during a quit attempt. DESIGN A 2 × 2 × 2 × 2 × 2 randomized factorial experiment. SETTING Eleven primary care clinics in Wisconsin, USA. PARTICIPANTS A total of 544 smokers (59% women, 86% white) recruited during primary care visits and motivated to quit. INTERVENTIONS Five intervention ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- European addiction research
دوره 19 6 شماره
صفحات -
تاریخ انتشار 2013